US Stock MarketDetailed Quotes
CSMYF COSMOS PHARMACEUTICAL CORP
- 78.600
- 0.0000.00%
15min DelayClose Jul 26 09:30 ET
3.11BMarket Cap19.60P/E (TTM)
0.000High0.000Low0Volume78.600Open78.600Pre Close0.00Turnover0.00%Turnover Ratio19.60P/E (Static)39.63MShares98.32052wk High2.07P/B3.11BFloat Cap78.43052wk Low0.76Dividend TTM39.63MShs Float98.320Historical High0.97%Div YieldTTM0.00%Amplitude78.430Historical Low--Avg Price1Lot Size
COSMOS PHARMACEUTICAL CORP Key Stats
Quarterly+Annual
YOY
| (FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | (FY)May 31, 2020 | (FY)May 31, 2019 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | ||||||
| Net income from continuing operations | 2.89%33.72B | -0.83%32.77B | -14.37%33.05B | 26.95%38.6B | 12.02%30.4B | --27.14B |
| Other non cash items | -41.69%1.75B | 308.54%3B | 14.64%-1.44B | -150.69%-1.69B | 226.27%3.33B | --1.02B |
| Change In working capital | -26.83%7.44B | 944.89%10.16B | 89.00%-1.2B | -142.42%-10.93B | 10,008.24%25.78B | --255M |
| -Change in receivables | -7.59%-1.83B | 10.53%-1.7B | -156.76%-1.9B | -227.43%-740M | 77.95%-226M | ---1.03B |
| -Change in inventory | 21.98%-8.7B | -90.60%-11.16B | 16.46%-5.85B | -2,274.92%-7.01B | 93.76%-295M | ---4.73B |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | 1.36%55.18B | 69.08%54.43B | 15.49%32.19B | -57.42%27.88B | 90.41%65.46B | --34.38B |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | ||||||
| Net PPE purchase and sale | -18.25%-55.09B | -10.99%-46.59B | -141.43%-41.98B | 32.99%-17.39B | 9.36%-25.95B | ---28.63B |
| Net other investing changes | 11.34%-2.24B | -45.08%-2.52B | 12.79%-1.74B | -97.82%-1.99B | 28.71%-1.01B | ---1.41B |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -16.73%-57.33B | -12.34%-49.11B | -125.57%-43.72B | 28.10%-19.38B | 10.27%-26.96B | ---30.04B |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | ||||||
| Net issuance payments of debt | 81.64%15.21B | 805.90%8.37B | 20.19%-1.19B | 0.00%-1.49B | 53.55%-1.49B | ---3.2B |
| Net common stock issuance | --0 | --0 | ---2M | --0 | ---- | --0 |
| Cash dividends paid | -42.65%-4.66B | 0.00%-3.27B | -43.43%-3.27B | -9.63%-2.28B | -16.62%-2.08B | ---1.78B |
| Net other financing activities | 66.67%-1M | -50.00%-3M | 0.00%-2M | 0.00%-2M | -100.00%-2M | ---1M |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 162.77%8.53B | 152.15%3.25B | -12.98%-6.22B | -1.89%-5.51B | 22.59%-5.41B | ---6.98B |
| Net cash flow | ||||||
| Beginning cash position | 22.93%45.93B | -32.20%37.36B | 5.73%55.11B | 174.01%52.12B | -12.21%19.02B | --21.67B |
| Current changes in cash | -25.60%6.37B | 148.27%8.57B | -694.07%-17.75B | -90.98%2.99B | 1,351.42%33.1B | ---2.65B |
| Effect of exchange rate changes | --0 | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 13.88%52.3B | 22.93%45.93B | -32.20%37.36B | 5.73%55.11B | 174.01%52.12B | --19.02B |
| Free cash flow | -108.14%-635M | 168.99%7.8B | -724.13%-11.3B | -95.42%1.81B | 640.08%39.51B | --5.34B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg